Stock Watch: Core Business Drags As Roche Disappoints And Sanofi Reclassifies

Q1 Earnings Highlight Plight Of Core Pharmaceutical Businesses

 
• By Andy Smith
Stock Watch Image, Andy Smith
ANDY SMITH OFFERS A LIFE SCIENCE INVESTOR'S PERSPECTIVE ON BIOPHARMA BUSINESS

More from Stock Watch

More from Business